Parasitology Research

, Volume 93, Issue 5, pp 364–368 | Cite as

Capillary damage in skeletal muscle in advanced Chagas’ disease patients

  • Sonia H. TorresEmail author
  • Héctor J. Finol
  • María Montes de Oca
  • Francia Vásquez
  • Juan J. Puigbó
  • José G. Loyo
Original Paper


The damage to skeletal muscle capillaries in advanced Chagas’ disease (stages II and III) was investigated in the vastus lateralis muscle of six patients and compared to that of six normal subjects. Capillaries were visualized by the PAS-amylase reaction and muscle fibres were classified by the ATPase histochemical method. Transmission electron microscopy was used to look for capillary alterations. The capillary-to-fibre ratio and number of capillaries adjacent to type I and type IIa fibres were decreased in the patient group. At the ultrastructural level, all patients showed capillary abnormalities, mainly basement membrane thickening and reduplication, capillary occlusion, proliferative endothelial cell cytoplasm with dense bodies, large vacuoles, altered mitochondria and prominent rough endoplasmic reticulum, as well as pericyte abnormalities. Capillary alterations are similar to those in patients affected by autoimmune diseases, suggesting an autoimmune component in the chronic phase of this disease. The reduction in capillarity may contribute to altered muscle performance in these patients.


Skeletal Muscle Amyotrophic Lateral Sclerosis Fibre Type Capillary Lumen Polyradiculoneuropathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors thank Ms. Beatriz Bello for technical help. This investigation was supported by grants from the Consejo Nacional de Investigaciones Científicas y Tecnológicas (S1-97001106) and Consejo de Desarrollo Científico y Humanístico, UCV, 09.33.4367.1999. The experiments comply with the current laws of Venezuela and were approved by the Ethics Committee of the University Hospital of Caracas.


  1. Andersen P (1975) Capillary density in skeletal muscles of man. Acta Physiol Scand 95:203–205PubMedGoogle Scholar
  2. Bergström J (1962) Muscle electrolytes in man. Scand J Clin Lab Invest 68:1–100Google Scholar
  3. Brooke MH, Kaiser KK (1970) Muscle fibers types: how many and what kind? Arch Neurol 23:369–379PubMedGoogle Scholar
  4. Cossio PM, Laguens RP, Diez C, Szareman A, Segal A, Arana RM (1974) Antibodies reacting with plasma membrane of striated muscle and endothelial cells. Circulation 50:1252–1259PubMedGoogle Scholar
  5. Duscha BD, Kraus WE, Keteyian SJ, Sullivan MJ, Green HJ, Schachat FH, Pippen AM, Brawner CA, Blank JM, Annex BH (1999) Capillary density of skeletal muscle. A contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol 33:1956–1963CrossRefPubMedGoogle Scholar
  6. Finol HJ, Montagnani S, Márquez A, Montes de Oca I, Müller B (1990) Ultrastructural pathology of skeletal muscle in systemic lupus erythematosus. J Rheumatol 17:210–219PubMedGoogle Scholar
  7. Finol HJ, Márquez A, Montes de Oca I, Müller B, Rivera H (1992) Muscle ultrastructure in some autoimmune diseases. Acta Microsc 1:55–62Google Scholar
  8. Finol HJ, Márquez A, Rivera H, Montes de Oca I, Müller B (1994) Ultrastructure of systemic sclerosis inflammatory myopathy. J. Submicrosc Cytol Pathol 26:245–253Google Scholar
  9. Gosker HR, Wouters EFM, Van der Vasse GJ, Schols AMWJ (2000) Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 71:1033–1047PubMedGoogle Scholar
  10. Jerusalem F, Rakusa M, Engel AG, MacDonald RD (1974) Morphometric analysis of skeletal muscle capillary ultrastructure in inflammatory myopathies. J Neurol Sci 23:391–402CrossRefPubMedGoogle Scholar
  11. Laguens RP, Cossio PM, Diez C, Segal A, Vasquez C, Kreutzer E, Khoury E, Arana RM (1975) Immunopathologic and morphologic studies of skeletal muscle in Chagas’ disease. Am J Pathol 80:153–62PubMedGoogle Scholar
  12. Laguens RP, Argel ML, Chambi J, Storino R, Cabeza Meckert PM (1994) Presence of antiheart and antiskeletal muscle glycolipid autoantibodies in the sera of patients with chagasic cardiopathy. Can J Cardiol 10:769–776PubMedGoogle Scholar
  13. Leiby DA, Herron RM, Read EJ, Lenes BA, Stumpf RJ (2002) Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 42:549–555CrossRefPubMedGoogle Scholar
  14. Mady C, Ianni BM, Arteaga E, Salemi VM, de Carvalho Frimm C (2000) Maximal functional capacity and diastolic function in patients with cardiomyopathy due to Chagas’ disease without congestive heart failure. J Card Fail 2000: 6:220–224Google Scholar
  15. McCormick TS, Rowland EC (1993) Trypanosoma cruzi: Recognition of a 43-kDa muscle glycoprotein by autoantibodies present during murine infection. Exp Parasitol 77:273–281CrossRefPubMedGoogle Scholar
  16. Oliveira MF, Bijovsky AT, Carvalho TU, De Souza W, Alves MJ, Colli W (2001) A monoclonal antibody to Trypanosoma cruzi trypomastigotes recognizes a myosin tail epitope. Parasitol Res 87:1043–1049PubMedGoogle Scholar
  17. Palacios-Prü, Carrasco H, Scorza C, Espinoza R (1989) Ultrastructural characteristics of different stages of human chagasic myocarditis. Am J Trop Med Hyg 41:29–40PubMedGoogle Scholar
  18. Pan American Health Organization (1984) Status of Chagas’ disease in the region of the Americas. Epidemiologic Bulletin, Pan American Health Organization, Washington, D.C.Google Scholar
  19. Puigbo JJ, Gordian H, Suarez C, et al (1992) Clinical aspects in Chagas’ disease. In: Madoery RJ, Madoery C, Camera MI (eds) Actualizaciones en la enfermedad de Chagas. Organismo Oficial del Congreso Nacional de Medicina, Buenos Aires, November 1992, pp 27–38Google Scholar
  20. Sica RE, González Cappa SM, Sanz OP, Mirkin G (1995) Peripheral nervous system involvement in human and experimental chronic American trypanosomiasis. Bull Soc Pathol Ex 88:156–63Google Scholar
  21. Tanowitz HB, Dhananjaya KK, Chen B, Morris SA, Factor SM, Weiss LM, Wittner M (1996) Compromised microcirculation in acute murine Trypanosoma cruzi infection. J Parasitol 82:124–130Google Scholar
  22. Tibbetts RS, McCormick TS, Rowland EC, Miller SD, Engman DM (1994) Cardiac antigen-specific autoantibody production is associated with cardiomyopathy in Trypanosoma cruzi-infected mice. J Immunol 152:1493–1499PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Sonia H. Torres
    • 1
    Email author
  • Héctor J. Finol
    • 2
  • María Montes de Oca
    • 3
  • Francia Vásquez
    • 3
  • Juan J. Puigbó
    • 4
  • José G. Loyo
    • 4
  1. 1.Institute of Experimental Medicine, Faculty of Medicine. Central University of VenezuelaCaracasVenezuela
  2. 2.Electron Microscopy Centre, Faculty of SciencesCentral University of VenezuelaCaracasVenezuela
  3. 3.Pulmonary Division, University Hospital of CaracasCentral University of VenezuelaCaracasVenezuela
  4. 4.Cardiomyopathy Unit, University Hospital of CaracasCentral University of VenezuelaCaracasVenezuela

Personalised recommendations